Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA-Cw6 allele and biologic therapy are protective factors against liver fibrosis in psoriatic arthritis patients.

Clinical and experimental rheumatology - 1 May 2023

Macía-Villa Cristina, Morell-Hita Jose Luis, Revenga-Martínez Marcelino, Díaz-Miguel Pérez Consuelo

Abstract excerpt

OBJECTIVES: To evaluate the association between liver fibrosis and the HLACw6 allele in psoriatic arthritis (PsA) patients. METHODS: A retrospective longitudinal study involving PsA patients with determination of the HLA-Cw6 allele was performed. Liver fibrosis was estimated by using the FIB-4 (fibrosis-4) score. A multivariate logistic model was undertaken to assess the odds ratio (OR), with its 95% confidence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Antirheumatic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Arthritis, Psoriatic

Share to HLA-C Antigens

Share to Liver Cirrhosis

Share to Longitudinal Studies

Share to Protective Factors

Share to Psoriasis

Source

Identifiers

PMID: 36700641
DOI: 10.55563/clinexprheumatol/anuuqb

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA-Cw6 allele and biologic therapy are protective factors against liver fibrosis in psoriatic arthritis patients.PMID 36700641Read ↗

HLA-Cw6 in Psoriatic Arthritis: Clinical Phenotype and Therapeutic Impact.Semantic proximity Read ↗

Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C∗06 Status.Semantic proximity Read ↗

Influence of the Hla-Cw6 Allele and <em>IFIH1/MDA5</em> Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic DiseaseSemantic proximity Read ↗

The HLA-Cw*06 allele may predict the response to methotrexate (MTX) treatment in Chinese arthritis-free psoriasis patients.Semantic proximity Read ↗

Searching for a Novel HLA-Cw6-Linked Cardiometabolic Endotype in Psoriatic DiseaseSemantic proximity Read ↗

Influence of IL-6 and TNF-α on clinical manifestations, activity and comorbidity in a group of patients with psoriatic arthritisSemantic proximity Read ↗

HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis.Semantic proximity Read ↗

HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population.Semantic proximity Read ↗

HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment.Semantic proximity Read ↗

Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes.Semantic proximity Read ↗

Correlation of HLA-Cw*06 allele frequency with some clinical features of psoriasis vulgaris in the population of northern Poland.Semantic proximity Read ↗

HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.